L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF
IE00BK5BC677
L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF/ IE00BK5BC677 /
NAV07/06/2024 |
Chg.-0.1073 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
11.4849USD |
-0.93% |
reinvestment |
Equity
Worldwide
|
LGIM Managers (EU) ▶ |
Stratégie d'investissement
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Shares in this Share Class (the "Shares") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com.The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine subsectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" (a measure of how actively its shares are traded on a daily basis).
Objectif d'investissement
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
ETF Stocks |
Benchmark: |
ROBO Global® Healthcare Technology and Innovation Index |
Début de l'exercice: |
01/07 |
Dernière distribution: |
- |
Banque dépositaire: |
The Bank of New York Mellon SA/NV |
Domicile: |
Ireland |
Permission de distribution: |
Austria, Germany, Switzerland |
Gestionnaire du fonds: |
- |
Actif net: |
71.42 Mio.
USD
|
Date de lancement: |
17/06/2019 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
0.00% |
Frais d'administration max.: |
0.49% |
Investissement minimum: |
1.00 USD |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
LGIM Managers (EU) |
Adresse: |
2 Dublin Landings, 1-W-131, Dublin |
Pays: |
Ireland |
Internet: |
www.lgim.com/ie/
|
Actifs
Stocks |
|
99.85% |
Cash |
|
0.12% |
Autres |
|
0.03% |
Pays
United States of America |
|
78.45% |
Switzerland |
|
5.47% |
Netherlands |
|
4.09% |
Jersey |
|
2.09% |
Italy |
|
1.96% |
Germany |
|
1.64% |
Luxembourg |
|
1.56% |
Canada |
|
1.27% |
China |
|
1.23% |
United Kingdom |
|
1.19% |
Japan |
|
0.90% |
Cash |
|
0.12% |
Autres |
|
0.03% |
Branches
Healthcare |
|
95.97% |
IT/Telecommunication |
|
2.65% |
Consumer goods |
|
1.23% |
Cash |
|
0.12% |
Autres |
|
0.03% |